Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA. (Q49585219)

21 February 2018

title

Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA. (English)

1 reference

21 February 2018

Trond Vidar Hansen

6

0 references

author name string

Karoline Gangestad Primdahl

1

1 reference

21 February 2018

Jørn Eivind Tungen

2

1 reference

21 February 2018

Patricia Regina Soares De Souza

3

1 reference

21 February 2018

Romain Alexandre Colas

4

1 reference

21 February 2018

Jesmond Dalli

5

1 reference

21 February 2018

Anders Vik

7

1 reference

21 February 2018

publication date

5 October 2017

1 reference

21 February 2018

Organic and Biomolecular Chemistry

published in

1 reference

21 February 2018

volume

15

1 reference

21 February 2018

issue

40

1 reference

21 February 2018

page(s)

8606-8613

1 reference

21 February 2018

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Pro-resolving lipid mediators are leads for resolution physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Resolution of inflammation: a new therapeutic frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Resolvins and protectins in inflammation resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

The Protectin PCTR1 Is Produced by Human M2 Macrophages and Enhances Resolution of Infectious Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Novel n-3 immunoresolvents: structures and actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Lipoxin biosynthesis and its impact in inflammatory and vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC7OB02113E

21 January 2018

Identifiers

DOI

10.1039/C7OB02113E

1 reference

21 February 2018

1 reference

21 February 2018